Sulfolipid-I (SL-I) is an abundant metabolite found in the cell wall of Mycobacterium tuberculosis that is comprised of a trehalose 2-sulfate core modified with four fatty acyl substituents. The correlation of its abundance with the virulence of clinical isolates suggests a role for SL-I in pathogenesis, although its biological functions remain unknown. Here we describe the synthesis of a SL-I analogue bearing unnatural lipid substituents. A key feature of the synthesis was application of an intramolecular aglycon delivery reaction to join two differentially protected glucose monomers, one prepared with a novel alpha-selective glycosylation. The route developed for the model compound can be readily extended to the synthesis of native SL-I as well as additional analogues for use in the investigation of SL-I's functions.
Synthetic Studies toward Mycobacterium tuberculosis Sulfolipid-I. Publishing Authors By Initials
Chemical & Substance for Abstract: Synthetic Studies toward Mycobacterium tuberculosis Sulfolipid-I. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Synthetic Studies toward Mycobacterium tuberculosis Sulfolipid-I.
AFFILIATION: Departments of Chemistry and Molecular and Cell Biology and Howard Hughes Medical Institute, University of California, and Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, California 94720.
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: J Org Chem
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Synthetic Studies toward Mycobacterium tuberculosis Sulfolipid-I Related Publications
